Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Category Archives: India Globalization Capital, Inc. IGC

India Globalization Capital, Inc. (NYSE: IGC) Announces Alzheimer’s Drug Candidate Targeting Aβ Proteins

Posted on September 12, 2017 by MissionIR

More than 5.3 million people in the U.S. have Alzheimer’s disease, which has no effective cure or substantial treatment India Globalization Capital’s IGC-ADI drug candidate targets proteins associated with the buildup of lesions in the brain The company acquired exclusive … Continue reading →

Posted in India Globalization Capital, Inc. IGC | Leave a comment

MissionIRNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Provides Update on Data Linking THC to Decrease in Aβ40 Protein Production

Posted on September 11, 2017 by MissionIR

India Globalization Capital, Inc. (NYSE American: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced compelling in vitro data compiled from genetically engineered cell lines showing that, at varying concentrations of THC, the … Continue reading →

Posted in India Globalization Capital, Inc. IGC, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – India Globalization Capital (NYSE: IGC) a Dark Horse in the Race to Treat Alzheimer’s

Posted on September 1, 2017 by MissionIR

Alzheimer’s is the most expensive disease in the United States, and pharmaceutical companies are racing to find viable treatments for this devastating disease, which currently affects more than 5.3 million Americans and their loved ones. Wall Street is placing bets … Continue reading →

Posted in India Globalization Capital, Inc. IGC, MissionIRNewsBreaks | Leave a comment

India Globalization Capital, Inc. (NYSE: IGC) Growth Potential Fueled by Phytocannabinoid Treatments

Posted on August 31, 2017 by MissionIR

Hyalolex for Alzheimer’s and other cannabis-based drugs for pain, epilepsy, and more are raising the market valuation growth potential for IGC Phytocannabinoids target protein receptors in the brain, peripheral nervous system and other parts of the body, including the lungs, … Continue reading →

Posted in India Globalization Capital, Inc. IGC | Leave a comment

India Globalization Capital, Inc. (NYSE: IGC) – The Pros are Already Picking Horses

Posted on August 29, 2017 by MissionIR

Alzheimer’s is America’s most expensive disease, with a new diagnosis every 66 seconds IGC’s unique use of marijuana extracts in combination therapy for potential Alzheimer’s breakthrough shows promise Low market cap could make IGC a big winner for early investors … Continue reading →

Posted in India Globalization Capital, Inc. IGC | Leave a comment

India Globalization Capital’s (NYSE: IGC) Cannabis-Based Alzheimer’s Disease Treatment Increases Upside Potential

Posted on August 22, 2017 by MissionIR

Alzheimer’s is a leading cause of dementia in adults in the United States IGC’s cannabis-based drug may reverse the buildup of beta-amyloid plaque Hyalolex and other phytocannabinoid-based drugs are fueling potential for the company’s market valuation growth Alzheimer’s disease is … Continue reading →

Posted in India Globalization Capital, Inc. IGC | Leave a comment

India Globalization Capital, Inc. (NYSE: IGC) Focuses on Building Phytocannabinoid-based Pharmaceutical Portfolio

Posted on August 21, 2017 by MissionIR

Core operations transitioned to phytocannabinoid-based therapies Four trial candidates targeting chronic pain, Alzheimer’s and other conditions Unique approach combining existing therapies with cannabinoids India Globalization Capital, Inc. (NYSE MKT: IGC) is developing disruptive new pharmaceutical therapies to fight a variety … Continue reading →

Posted in India Globalization Capital, Inc. IGC | Leave a comment

MissionIRNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Reports Financial Results for Quarter Ended June 30, 2017

Posted on August 21, 2017 by MissionIR

India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced its financial results for the quarter ended June 30, 2017. “During the quarter, we secured an IP licensing … Continue reading →

Posted in India Globalization Capital, Inc. IGC, MissionIRNewsBreaks | Leave a comment

India Globalization Capital (NYSE: IGC) Shows Potential for Strong Market Valuation Growth

Posted on August 16, 2017 by MissionIR

India Globalization Capital recently acquired exclusive patent rights for the use of low-dose THC as a potential therapeutic agent for Alzheimer’s disease No other publicly traded cannabis pharmaceutical company has a patent filing for a potential Alzheimer’s treatment Costs associated … Continue reading →

Posted in India Globalization Capital, Inc. IGC | Leave a comment

India Globalization Capital, Inc. (NYSE: IGC) – Blockbuster Position for Treating Alzheimer’s

Posted on August 4, 2017 by MissionIR

IGC purchased exclusive rights to USF patent focused on preventing amyloid-beta plaques from aggregating on neurons Company plans to pursue clinical trials related to this patent on path to FDA approval In 2017, direct costs associated with Alzheimer’s and other … Continue reading →

Posted in India Globalization Capital, Inc. IGC | Leave a comment